These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Nitrogen mustard therapy of proliferative blood diseases; methods, experiences as well as application possibilities in therapy of carcinoma]. KLIMA R; HORNISCHER R Wien Med Wochenschr; 1953 Jan; 103(1):11-4. PubMed ID: 13049846 [No Abstract] [Full Text] [Related]
5. Chemotherapy in the reticuloses. MELICK RA Med J Aust; 1952 Jan; 1(2):38-43. PubMed ID: 14909886 [No Abstract] [Full Text] [Related]
6. The role of chemotherapy in the management of malignant lymphomas and leukemias. RUNDLES RW; BARTON WB; COONRAD EV South Med J; 1953 Mar; 46(3):259-68. PubMed ID: 13038539 [No Abstract] [Full Text] [Related]
7. [Mustard gas and urethane; their effects on the pelvic metastasis of cancer of the uterine cervix]. DALL'ARMELLINA PJ Prensa Med Argent; 1955 Jul; 42(28):2115-8. PubMed ID: 13273297 [No Abstract] [Full Text] [Related]
8. Multiple myelomatosis treated with a combination of urethane and an oral nitrogen mustard. INNES J; RIDER WD Blood; 1955 Mar; 10(3):252-8. PubMed ID: 14351248 [No Abstract] [Full Text] [Related]
9. [About Combined N-Lost Urethane Therapy for Chronic Myeloses]. KEIBL E Wien Klin Wochenschr; 1955 May; 67(20):356-61. PubMed ID: 14397349 [No Abstract] [Full Text] [Related]
10. [On the problem of mycosis fungoides]. GABRIEL H; NEUHOLD R Arch Dermatol Syph; 1953; 196(5):445-64. PubMed ID: 13125413 [No Abstract] [Full Text] [Related]
11. [Problems of leucocyte metabolism. III. Effects of nitrogen mustard and nitrogen mustard in combination with urethan on the metabolism of cells of myeloid leukemia]. KEIBL E; SPITZY KH; STORCH L Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1952; 214(5):534-9. PubMed ID: 14953257 [No Abstract] [Full Text] [Related]
12. [Propagated chorioepithelioma treated by intra-arterial chemotherapy]. MONACO H; SCHAVELZON E; ALFAYA H Prensa Med Argent; 1955 Nov; 42(44):3353-5. PubMed ID: 13310465 [No Abstract] [Full Text] [Related]
13. Comparison of CB-1348 (chlorambucil, leukeran) and CB-1364. RUNDLES W; GRIZZLE J; BONO VH; JONSSON U; HUGULEY CM; CORLEY CC Cancer Chemother Rep; 1962 Feb; 16():223-30. PubMed ID: 14495284 [No Abstract] [Full Text] [Related]
14. [A case of chronic myelogenous leucaemia treated with nitrogen mustard N-oxide]. KUROYANAGI S Gan; 1953 Sep; 44(2-3):397-8. PubMed ID: 13128215 [No Abstract] [Full Text] [Related]
15. [Kinetic criteria of the effectiveness of treatment of chronic myeloleukosis]. Levitin EI; Kukharenko IuA; Gor'kov VA; Evseenko LS Izv Akad Nauk SSSR Biol; 1973; 4():566-72. PubMed ID: 4518679 [No Abstract] [Full Text] [Related]
16. [Panmyelophthisis during the treatment of myelocytic leukemic with urethane]. ANTIC M Vojnosanit Pregl; 1955; 12(5-6):294-8. PubMed ID: 13257043 [No Abstract] [Full Text] [Related]
17. [Treatment of hematologic neoplasms with nitrogen oxide mustards]. HORLIN W; SCHMITT W Dtsch Med Wochenschr; 1957 Feb; 82(7):247-50. PubMed ID: 13427484 [No Abstract] [Full Text] [Related]
18. SYNTHESIS OF N-PHOSPHORYLATED DERIVATIVES OF NITROGEN MUSTARDS WITH LATENT CYTOTOXICITY. FRIEDMAN OM; BOGER E; GRUBLIAUSKAS V; SOMMER H J Med Chem; 1963 Jan; 6():50-8. PubMed ID: 14174031 [No Abstract] [Full Text] [Related]
19. [Malignant growth and pharmacotherapy]. von KRESS H Arztl Wochensch; 1950 Jun; 5(23):381-4. PubMed ID: 15425420 [No Abstract] [Full Text] [Related]
20. [Efficacy and limitations of karyoklastic therapy of leukosis, lymphogranulomatosis, and malignant tumors in childhood]. WEICKER H Kinderarztl Prax; 1950; 18():143-50. PubMed ID: 14785133 [No Abstract] [Full Text] [Related] [Next] [New Search]